BA vs REGN · P/E 89, rev $89.46B vs P/E 14, rev $14.34B
The Boeing Company (BA) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
The Boeing Company (BA) is a aerospace & defense company listed on NYSE. It is led by Kelly Ortberg.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported BA revenue for 2025-12-31 was $89.46B. Net income was $2.23B. Revenue was up 34.5% from 2024-12-31 to 2025-12-31. BA currently screens at market cap $177.86B and trailing P/E 89.2.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
BA currently screens at market cap $177.86B and trailing P/E 89.2. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the BA and REGN stock pages for the full models.
Not investment advice.